{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T03:05:19Z","timestamp":1774321519628,"version":"3.50.1"},"reference-count":43,"publisher":"American Diabetes Association","issue":"3","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,3,1]]},"abstract":"<jats:p>Islet transplantation represents a potential cure for type 1 diabetes, yet persistent autoimmune and allogeneic immunities currently limit its clinical efficacy. For alleviating the autoimmune destruction of transplanted islets, newly diagnosed NOD mice were provided a single intramuscular injection of recombinant adeno-associated viral vector encoding murine IL-10 (rAAV-IL-10) 4 weeks before renal capsule delivery of 650 syngeneic islets. A dose-dependent protection of islet grafts was observed. Sixty percent (3 of 5) of NOD mice that received a transduction of a high-dose (4 \u00d7 109 infectious units) rAAV-IL-10 remained normoglycemic for at least 117 days, whereas diabetes recurred within 17 days in mice that received a low-dose rAAV-IL-10 (4 \u00d7 108 infectious units; 5 of 5) as well as in all of the control mice (5 of 5 untreated and 4 of 4 rAAV-green fluorescent protein-transduced). Serum IL-10 levels positively correlated with prolonged graft survival and were negatively associated with the intensity of autoimmunity. The mechanism of rAAV-IL-10 protection involved a reduction of lymphocytic infiltration as well as induction of antioxidant enzymes manganese superoxide dismutase and heme oxygenase 1 in islet grafts. These studies support the utility of immunoregulatory cytokine gene therapy delivered by rAAV for preventing autoimmune disease recurrence in transplant-based therapies for type 1 diabetes.<\/jats:p>","DOI":"10.2337\/diabetes.52.3.708","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"708-716","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":86,"title":["Adeno-Associated Virus-Mediated IL-10 Gene Therapy Inhibits Diabetes Recurrence in Syngeneic Islet Cell Transplantation of NOD Mice"],"prefix":"10.2337","volume":"52","author":[{"given":"Y. Clare","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Florida, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonello","family":"Pileggi","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, University of Miami, Miami, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anupam","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Florida, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Damaris","family":"Molano","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, University of Miami, Miami, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Powers","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Florida, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Brusko","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Florida, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clive","family":"Wasserfall","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Florida, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Goudy","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Florida, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsie","family":"Zahr","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, University of Miami, Miami, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Poggioli","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, University of Miami, Miami, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marda","family":"Scott-Jorgensen","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Florida, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Campbell-Thompson","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Florida, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Crawford","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Florida, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Nick","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, University of Florida, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence","family":"Flotte","sequence":"additional","affiliation":[{"name":"Genetics Institute, University of Florida, Gainesville, Florida"},{"name":"Powell Gene Therapy Center, University of Florida, Gainesville, Florida"},{"name":"Department of Pediatrics, University of Florida, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamir M.","family":"Ellis","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Florida, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camillo","family":"Ricordi","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, University of Miami, Miami, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Inverardi","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, University of Miami, Miami, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Florida, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","reference":[{"key":"2022031215430712500_R1","doi-asserted-by":"crossref","unstructured":"Atkinson MA, Leiter EH: The NOD mouse model of type 1 diabetes: as good as it gets?Nat Med\u20085:601\u2013604,1999","DOI":"10.1038\/9442"},{"key":"2022031215430712500_R2","doi-asserted-by":"crossref","unstructured":"Wong FS, Janeway CAJ: The role of CD4 vs. CD8 T cells in IDDM. J Autoimmun\u200813:290\u2013295,1999","DOI":"10.1006\/jaut.1999.0322"},{"key":"2022031215430712500_R3","doi-asserted-by":"crossref","unstructured":"Rabinovitch A: Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?Diabetes\u200843:613\u2013621,1994","DOI":"10.2337\/diabetes.43.5.613"},{"key":"2022031215430712500_R4","doi-asserted-by":"crossref","unstructured":"Prud\u2019homme GJ: Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors. J Gene Med\u20082:222\u2013232,2000","DOI":"10.1002\/1521-2254(200007\/08)2:4<222::AID-JGM117>3.0.CO;2-P"},{"key":"2022031215430712500_R5","doi-asserted-by":"crossref","unstructured":"Moore KW, de Waal M, Coffman RL, O\u2019Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol\u200819:683\u2013765,2001","DOI":"10.1146\/annurev.immunol.19.1.683"},{"key":"2022031215430712500_R6","doi-asserted-by":"crossref","unstructured":"Szelachowska M, Kretowski A, Kinalska I: Decreased in vitro IL-4 [corrected] and IL-10 production by peripheral blood in first degree relatives at high risk of diabetes type-I. Horm Metab Res\u200830:526\u2013530,1998","DOI":"10.1055\/s-2007-978926"},{"key":"2022031215430712500_R7","doi-asserted-by":"crossref","unstructured":"Alleva DG, Pavlovich RP, Grant C, Kaser SB, Beller DI: Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-\u03b1 and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes\u200849:1106\u20131115,2000","DOI":"10.2337\/diabetes.49.7.1106"},{"key":"2022031215430712500_R8","doi-asserted-by":"crossref","unstructured":"Balasa B, Van Gunst K, Jung N, Katz JD, Sarvetnick N: IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse. Cell Immunol\u2008202:97\u2013102,2000","DOI":"10.1006\/cimm.2000.1658"},{"key":"2022031215430712500_R9","doi-asserted-by":"crossref","unstructured":"Pennline KJ, Roque-Gaffney E, Monahan M: Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol\u200871:169\u2013175,1994","DOI":"10.1006\/clin.1994.1068"},{"key":"2022031215430712500_R10","doi-asserted-by":"crossref","unstructured":"Balasa B, Sarvetnick N: The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes. J Autoimmun\u20089:283\u2013286,1996","DOI":"10.1006\/jaut.1996.0036"},{"key":"2022031215430712500_R11","doi-asserted-by":"crossref","unstructured":"Goudy K, Song S, Wasserfall C, Zhang YC, Kapturczak M, Muir A, Powers M, Scott-Jorgensen M, Campbell-Thompson M, Crawford JM, Ellis TM, Flotte T, Atkinson MA: Adeno-associated virus vector mediated interleukin-10 gene delivery prevents type 1 diabetes in NOD mice. Proc Natl Acad Sci U S A\u200898:13913\u201313918,2001","DOI":"10.1073\/pnas.251532298"},{"key":"2022031215430712500_R12","doi-asserted-by":"crossref","unstructured":"Nitta Y, Tashiro F, Tokui M, Shimada A, Takei I, Tabayashi K, Miyazaki J: Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice. Hum Gene Ther\u20089:1701\u20131707,1998","DOI":"10.1089\/hum.1998.9.12-1701"},{"key":"2022031215430712500_R13","doi-asserted-by":"crossref","unstructured":"Moritani M, Yoshimoto K, Tashiro F, Hashimoto C, Miyazaki J, Ii S, Kudo E, Iwahana H, Hayashi Y, Sano T: Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int Immunol\u20086:1927\u20131936,1994","DOI":"10.1093\/intimm\/6.12.1927"},{"key":"2022031215430712500_R14","doi-asserted-by":"crossref","unstructured":"Wogensen L, Lee MS, Sarvetnick N: Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. J Exp Med\u2008179:1379\u20131384,1994","DOI":"10.1084\/jem.179.4.1379"},{"key":"2022031215430712500_R15","doi-asserted-by":"crossref","unstructured":"Smith DK, Korbutt GS, Suarez-Pinzon WL, Kao D, Rajotte RV, Elliott JF: Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice. Transplantation\u200864:1040\u20131049,1997","DOI":"10.1097\/00007890-199710150-00017"},{"key":"2022031215430712500_R16","doi-asserted-by":"crossref","unstructured":"Yasuda H, Nagata M, Arisawa K, Yoshida R, Fujihira K, Okamoto N, Moriyama H, Miki M, Saito I, Hamada H, Yokono K, Kasuga M: Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice. J Clin Invest\u2008102:1807\u20131814,1998","DOI":"10.1172\/JCI2675"},{"key":"2022031215430712500_R17","doi-asserted-by":"crossref","unstructured":"Pileggi A, Ricordi C, Alessiani M, Inverardi L: Factors influencing Islet of Langerhans graft function and monitoring. Clin Chim Acta\u2008310:3\u201316,2001","DOI":"10.1016\/S0009-8981(01)00503-4"},{"key":"2022031215430712500_R18","doi-asserted-by":"crossref","unstructured":"Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF, Rajotte RV: Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice: analysis of cytokine mRNA expression in the graft. Transplantation\u200860:368\u2013374,1995","DOI":"10.1097\/00007890-199508270-00012"},{"key":"2022031215430712500_R19","doi-asserted-by":"crossref","unstructured":"Rabinovitch A, Sorensen O, Suarez-Pinzon WL, Power RF, Rajotte RV, Bleackley RC: Analysis of cytokine mRNA expression in syngeneic islet grafts of NOD mice: interleukin 2 and interferon gamma mRNA expression correlate with graft rejection and interleukin 10 with graft survival. Diabetologia\u200837:833\u2013837,1994","DOI":"10.1007\/BF00404341"},{"key":"2022031215430712500_R20","doi-asserted-by":"crossref","unstructured":"Rabinowitz JE, Samulski J: Adeno-associated virus expression systems for gene transfer. Curr Opin Biotechnol\u20089:470\u2013475,1998","DOI":"10.1016\/S0958-1669(98)80031-1"},{"key":"2022031215430712500_R21","doi-asserted-by":"crossref","unstructured":"Song S, Morgan M, Ellis T, Poirier A, Chesnut K, Wang J, Brantly M, Muzyczka N, Byrne BJ, Atkinson M, Flotte TR: Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci U S A\u200895:14384\u201314388,1998","DOI":"10.1073\/pnas.95.24.14384"},{"key":"2022031215430712500_R22","doi-asserted-by":"crossref","unstructured":"Pileggi A, Molano RD, Berney T, Cattan P, Vizzardelli C, Oliver R, Fraker C, Ricordi C, Pastori RL, Bach FH, Inverardi L: Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes\u200850:1983\u20131991,2001","DOI":"10.2337\/diabetes.50.9.1983"},{"key":"2022031215430712500_R23","doi-asserted-by":"crossref","unstructured":"Rabinovitch A: An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev\u200814:129\u2013151,1998","DOI":"10.1002\/(SICI)1099-0895(199806)14:2<129::AID-DMR208>3.0.CO;2-V"},{"key":"2022031215430712500_R24","doi-asserted-by":"crossref","unstructured":"Mosmann TR, Coffman RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol\u20087:145\u2013173,1989","DOI":"10.1146\/annurev.iy.07.040189.001045"},{"key":"2022031215430712500_R25","doi-asserted-by":"crossref","unstructured":"Hall BM: Cells mediating allograft rejection. Transplantation\u200851:1141\u20131151,1991","DOI":"10.1097\/00007890-199106000-00001"},{"key":"2022031215430712500_R26","doi-asserted-by":"crossref","unstructured":"Sutherland DE, Goetz FC, Sibley RK: Recurrence of disease in pancreas transplants. Diabetes\u200838 (Suppl. 1):85\u201387,1989","DOI":"10.2337\/diab.38.1.S85"},{"key":"2022031215430712500_R27","doi-asserted-by":"crossref","unstructured":"Markees TG, Serreze DV, Phillips NE, Sorli CH, Gordon EJ, Shultz LD, Noelle RJ, Woda BA, Greiner DL, Mordes JP, Rossini AA: NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes\u200848:967\u2013974,1999","DOI":"10.2337\/diabetes.48.5.967"},{"key":"2022031215430712500_R28","doi-asserted-by":"crossref","unstructured":"Ryu S, Kodama S, Ryu K, Schoenfeld DA, Faustman DL: Reversal of established autoimmune diabetes by restoration of endogenous beta cell function. J Clin Invest\u2008108:63\u201372,2001","DOI":"10.1172\/JCI12335"},{"key":"2022031215430712500_R29","doi-asserted-by":"crossref","unstructured":"Lakey JR, Singh B, Warnock GL, Rajotte RV: BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice. Transplantation\u200857:1213\u20131217,1994","DOI":"10.1097\/00007890-199404270-00013"},{"key":"2022031215430712500_R30","doi-asserted-by":"crossref","unstructured":"Shapiro AM, Suarez-Pinzon WL, Power R, Rabinovitch A: Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice. Diabetologia\u200845:224\u2013230,2002","DOI":"10.1007\/s00125-001-0745-x"},{"key":"2022031215430712500_R31","doi-asserted-by":"crossref","unstructured":"Sandberg JO, Eizirik DL, Sandler S: IL-1 receptor antagonist inhibits recurrence of disease after syngeneic pancreatic islet transplantation to spontaneously diabetic non-obese diabetic (NOD) mice. Clin Exp Immunol\u2008108:314\u2013317,1997","DOI":"10.1046\/j.1365-2249.1997.3771275.x"},{"key":"2022031215430712500_R32","doi-asserted-by":"crossref","unstructured":"Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Rajotte RV, Power RF: TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice. J Immunol\u2008159:6298\u20136303,1997","DOI":"10.4049\/jimmunol.159.12.6298"},{"key":"2022031215430712500_R33","doi-asserted-by":"crossref","unstructured":"Teros T, Hakala R, Ylinen L, Liukas A, Arvilommi P, Sainio-Pollanen S, Verajankorva E, Pollanen P, Simell O: Cytokine balance and lipid antigen presentation in the NOD mouse pancreas during development of insulitis. Pancreas\u200820:191\u2013196,2000","DOI":"10.1097\/00006676-200003000-00013"},{"key":"2022031215430712500_R34","doi-asserted-by":"crossref","unstructured":"Phillips JM, Parish NM, Drage M, Cooke A: Cutting edge: interactions through the IL-10 receptor regulate autoimmune diabetes. J Immunol\u2008167:6087\u20136091,2001","DOI":"10.4049\/jimmunol.167.11.6087"},{"key":"2022031215430712500_R35","doi-asserted-by":"crossref","unstructured":"Liu Y, Liggitt HD, Dow S, Handumrongkul C, Heath TD, Debs RJ: Strain-based genetic differences regulate the efficiency of systemic gene delivery as well as expression. J Biol Chem\u2008277:4966\u20134972,2002","DOI":"10.1074\/jbc.M110285200"},{"key":"2022031215430712500_R36","doi-asserted-by":"crossref","unstructured":"Ito K, Takeuchi Y, Kato S: Strain-dependent antibody response induced by DNA immunization. Immunol Lett\u200874:245\u2013250,2000","DOI":"10.1016\/S0165-2478(00)00266-2"},{"key":"2022031215430712500_R37","doi-asserted-by":"crossref","unstructured":"Ding Y, Qin L, Kotenko SV, Pestka S, Bromberg JS: A single amino acid determines the immunostimulatory activity of interleukin 10. J Exp Med\u2008191:213\u2013224,2000","DOI":"10.1084\/jem.191.2.213"},{"key":"2022031215430712500_R38","doi-asserted-by":"crossref","unstructured":"Lee TS, Chau LY: Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med\u20088:240\u2013246,2002","DOI":"10.1038\/nm0302-240"},{"key":"2022031215430712500_R39","doi-asserted-by":"crossref","unstructured":"Otterbein LE, Bach FH, Alam J, Soares M, Tao LH, Wysk M, Davis RJ, Flavell RA, Choi AM: Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med\u20086:422\u2013428,2000","DOI":"10.1038\/74680"},{"key":"2022031215430712500_R40","doi-asserted-by":"crossref","unstructured":"Gunther L, Berberat PO, Haga M, Brouard S, Smith RN, Soares MP, Bach FH, Tobiasch E: Carbon monoxide protects pancreatic \u03b2-cells from apoptosis and improves islet function\/survival after transplantation. Diabetes\u200851:994\u2013999,2002","DOI":"10.2337\/diabetes.51.4.994"},{"key":"2022031215430712500_R41","doi-asserted-by":"crossref","unstructured":"Dokka S, Shi X, Leonard S, Wang L, Castranova V, Rojanasakul Y: Interleukin-10-mediated inhibition of free radical generation in macrophages. Am J Physiol Lung Cell Mol Physiol\u2008280:L1196\u2013L1202,2001","DOI":"10.1152\/ajplung.2001.280.6.L1196"},{"key":"2022031215430712500_R42","doi-asserted-by":"crossref","unstructured":"Gunnett CA, Heistad DD, Berg DJ, Faraci FM: IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am J Physiol Heart Circ Physiol\u2008279:H1555\u2013H1562,2000","DOI":"10.1152\/ajpheart.2000.279.4.H1555"},{"key":"2022031215430712500_R43","doi-asserted-by":"crossref","unstructured":"Lebovitz RM, Zhang H, Vogel H, Cartwright JJ, Dionne L, Lu N, Huang S, Matzuk MM: Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci U S A\u200893:9782\u20139787,1996","DOI":"10.1073\/pnas.93.18.9782"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/52\/3\/708\/373493\/db0303000708.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/52\/3\/708\/373493\/db0303000708.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T21:53:20Z","timestamp":1683755600000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/52\/3\/708\/23956\/Adeno-Associated-Virus-Mediated-IL-10-Gene-Therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,1]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.52.3.708","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,1]]}}}